Trial Profile
Retrospective, single center, open label trial of rufinamide in Korean children with Lennox-Gastaut syndrome
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 Feb 2016
Price :
$35
*
At a glance
- Drugs Rufinamide (Primary)
- Indications Lennox-Gastaut syndrome
- Focus Therapeutic Use
- 22 Feb 2016 New trial record